Brightstar Associates LLC 4
4 · Deciphera Pharmaceuticals, Inc. · Filed Oct 2, 2017
Insider Transaction Report
Form 4
Brightstar Associates LLC
10% Owner
Transactions
- Conversion
Series B Preferred Stock
2017-10-02−297,030→ 0 total→ Common Stock (1,678,219 underlying) - Conversion
Common Stock
2017-10-02+16,572,370→ 16,572,370 total - Conversion
Series A Preferred Stock
2017-10-02−1,976,134→ 0 total→ Common Stock (11,165,157 underlying) - Conversion
Series C Preferred Stock
2017-10-02−263,991→ 0 total→ Common Stock (1,491,549 underlying) - Conversion
Series B-1 Preferred Stock
2017-10-02−396,008→ 0 total→ Common Stock (2,237,445 underlying)
Footnotes (1)
- [F1]Represents preferred stock of Deciphera Pharmaceuticals, LLC. Upon the closing of the Issuer's initial public offering, each share of preferred stock was automatically converted into 5.65 shares of common stock of the Issuer.